Project Grant R00DK136921
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Chicago a $6.51 million Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 20, 2025, with a completion date of September 19, 2029. This award funds research investigating the role of macrophages in weight loss-induced metabolic health and adipose tissue inflammation resolution. The project addresses...
- Federal Project Grant Award Summary The University of Massachusetts Medical School received a $2.64 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2029. This award funds biomedical research investigating novel mitochondrial mechanisms underlying obesity pathogenesis, with specific focus on...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Tufts University School of Medicine a $232,000 Project Grant on March 12, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports fundamental research investigating the role of Interferon Regulatory Factor 8 (IRF8), a transcription factor expressed in adipocytes, in regulating white and brown adipose tissue metabolism...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Washington University a Project Grant totaling $233,250 on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports research into the role of protein phosphatase 1K (PPM1K) in macrophage activation and metabolic disease. The research addresses a critical knowledge gap regarding branched chain amino...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Illinois at Chicago $786,728 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on June 1, 2026, with a completion date of April 30, 2031. This Project Grant funds basic biomedical research investigating the role of gut microbiota-derived 3-phenylpropionic acid (3-PPA) as a metabolic modulator of beige adipogenesis...
- Federal Project Grant Award Summary The University of Chicago received a $123,000 Project Grant award dated June 16, 2026, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, with an ultimate completion date of May 31, 2028, funds research to characterize adipocyte heterogeneity in response to metabolic stress. The research employs single nucleus RNA sequencing...
- Federal Project Grant Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Trustees of Columbia University in the City of New York a Project Grant totaling $246,750 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective August 15, 2025, through August 14, 2027, funds research investigating the mechanisms of pancreatic inflammation in obesity. The research addresses how obesity alters...
- Federal Project Grant Award Summary Award Details: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Tufts University School of Medicine a Project Grant of $735,358 on May 21, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award extends through February 28, 2030, and is performed in Boston, Massachusetts. Research Products and Services: This project grant funds basic biomedical research investigating...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $451,000 Project Grant to The Regents of the University of California, San Francisco on September 5, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a two-year research initiative (completion by August 31, 2027) investigating the role of microRNAs in adipose tissue dysfunction among people with HIV (PWH) who...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $140,116.00 to the Beckman Research Institute of the City of Hope on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support basic biomedical research on gut-fat crosstalk in metabolic regulation through July 31, 2028. The research project investigates the mechanisms of communication between the intestine...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded University of Maryland Baltimore County a Project Grant in the amount of $249,000 on July 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds research through March 31, 2029, to delineate the role of macrophage-derived transglutaminases in adipose tissue health and inflammation associated with obesity. This extramural research project supports fundamental and clinical biomedical investigation aligned with NIDDK's programmatic priorities in metabolic disorders, obesity research, and inflammatory mechanisms underlying metabolic disease. The research deliverables will advance understanding of enzyme-mediated pathways in obesity-related inflammation and adipose tissue dysfunction. As a Project Grant—the predominant assistance type within the NIDDK extramural research portfolio—the award supports peer-reviewed, competitive scientific investigation with expected outcomes to include publications, data, and mechanistic insights relevant to obesity prevention and treatment strategies. UMBC will serve as the prime research performer, conducting the work at its Bethesda, Maryland location.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $249.0k | 7/15/26 |